MedTrace Logo

Predicting Outcomes for Covid-19 Using Sonography

NCT04384055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2021-12-03

No results posted yet for this study

Summary

This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early in the disease course.

Conditions

Interventions

DIAGNOSTIC_TEST

Lung Ultrasound

Lung ultrasound will be performed on patients undergoing investigation for covid-19 based on a nasopharyngeal PCR.

Sponsors & Collaborators

Principal Investigators

  • Andre D Kumar, MD, MEd · Stanford University

  • Sally Graglia, MD, MPH · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-21
Primary Completion
2021-11-15
Completion
2021-11-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04384055 on ClinicalTrials.gov